Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Carboxymethylcellulose Sodium, Glycerin And Polysorbate 80
Brand Name
Refresh Optive Mega-3
Generic Name
Carboxymethylcellulose Sodium, Glycerin And Polysorbate 80
Active Ingredient
CarboxymethylcelluloseCategory
Non-Standardized Chemical Allergen [EPC]
Salt Form
Sodium
Variants
3
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Refresh Optive Mega-3, you must consult a qualified healthcare professional.
Detailed information about Refresh Optive Mega-3
Carboxymethylcellulose sodium is a high-viscosity polymer used primarily as an ophthalmic lubricant for dry eye relief and as a pharmaceutical excipient. It belongs to the class of non-standardized chemical allergens when used in diagnostic testing.
For the treatment of dry eye symptoms and ocular irritation, the standard adult dosage of Carboxymethylcellulose sodium (0.5% or 1.0%) is 1 to 2 drops in the affected eye(s) as needed.
Carboxymethylcellulose is generally considered safe for pediatric use, as it is not systemically absorbed. However, there is no standardized 'pediatric dose' established by the FDA. Healthcare providers typically recommend the same 'as needed' frequency as adults (1-2 drops). Parents should consult a pediatrician before using any eye drops in children under the age of 6 to ensure the symptoms are not caused by an underlying infection or allergy that requires different treatment.
No dosage adjustments are necessary for patients with kidney disease. Because Carboxymethylcellulose is not absorbed into the bloodstream, renal clearance is not a factor in its use or safety profile.
No dosage adjustments are required for patients with liver disease. The drug does not undergo hepatic metabolism (it is not processed by the liver).
Elderly patients often suffer from age-related dry eye (aqueous deficiency). No specific dose adjustment is needed, but elderly patients may prefer preservative-free vials if they have fragile ocular surfaces or are using multiple other ophthalmic medications for conditions like glaucoma.
Proper administration is crucial to ensure efficacy and prevent contamination:
Since Carboxymethylcellulose is typically used on an 'as needed' basis, a missed dose is not clinically significant. If you are on a schedule and miss a dose, simply apply the drops as soon as you remember. Do not 'double up' the drops; the eye can only hold about one-tenth of a single drop at a time, so extra drops will simply run down your cheek.
An overdose of Carboxymethylcellulose in the eye is virtually impossible, as the excess fluid will simply drain out of the eye. However, if the solution is accidentally swallowed, it is generally non-toxic. In large quantities, oral ingestion might cause mild gastrointestinal upset or a laxative effect. If a child swallows a large amount of the solution, contact a Poison Control Center or seek emergency medical attention as a precaution, primarily due to the other ingredients (preservatives/buffers) in the solution.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
Most patients tolerate Carboxymethylcellulose exceptionally well. However, because it is a viscosifying agent, the most common side effect is transient blurred vision. This typically feels like a 'filmy' sensation over the eye immediately after application. It usually lasts for 30 seconds to 2 minutes as the drop spreads across the ocular surface.
Other common experiences include:
Some patients may experience slightly more persistent symptoms, including:
Carboxymethylcellulose is an over-the-counter (OTC) medication, but it must be used with the same caution as any prescription drug. The most critical safety factor is maintaining the sterility of the solution. Because the eye is highly susceptible to infection, any bacteria introduced into the bottle can multiply and cause sight-threatening conditions like bacterial keratitis (infection of the cornea).
No FDA black box warnings for Carboxymethylcellulose.
As its classification as a Non-Standardized Chemical Allergen [EPC] suggests, some individuals may have a pre-existing sensitivity to cellulose derivatives. If you have had a reaction to other eye drops, ultrasound gels, or certain food thickeners, you should inform your doctor. Symptoms of an allergic reaction include eyelid itching, swelling, and hives.
There are no known systemic drug-drug contraindications for Carboxymethylcellulose because it is not absorbed into the bloodstream. However, from a physical standpoint, it should not be mixed directly in the eye with other ophthalmic medications unless specifically directed by a physician. Mixing different types of eye drops can change the pH and osmolarity, potentially causing irritation or reducing the effectiveness of both drugs.
While not 'serious' in a life-threatening sense, the use of CMC can interfere with the absorption of other topical ophthalmic medications. Because CMC creates a mucoadhesive barrier on the eye, it can prevent other drugs—such as Glaucoma drops (Prostalglandin analogs, Beta-blockers) or Antibiotic drops—from reaching the corneal surface.
Carboxymethylcellulose must NEVER be used in the following circumstances:
Carboxymethylcellulose sodium is a high-molecular-weight polymer that is not absorbed systemically following topical ophthalmic or oral administration. Because there is no systemic exposure, it is highly unlikely to reach the developing fetus. There are no known reports of teratogenicity (birth defects) associated with CMC. It is widely considered the first-line treatment for 'pregnancy-induced dry eye,' which occurs due to hormonal shifts. However, as with all medications, pregnant women should consult their obstetrician before use.
It is not known whether Carboxymethylcellulose is excreted in human milk. However, because systemic absorption is negligible, the concentration in breast milk would be expected to be zero. There is no known risk to the nursing infant. It is considered compatible with breastfeeding.
Carboxymethylcellulose is frequently used in children for the treatment of environmental eye irritation or juvenile dry eye. There are no specific age-related restrictions. The primary concern in pediatric populations is the physical administration of the drops (avoiding injury to the eye with the dropper) and ensuring that the symptoms are not actually caused by viral or bacterial conjunctivitis ('pink eye'), which is common in school-aged children.
Carboxymethylcellulose (CMC) is a mucomimetic polymer. Its molecular structure consists of a cellulose backbone with glucopyranose units that have been substituted with carboxymethyl groups. This structure gives the molecule a strong negative charge (anionic).
In the eye, the mechanism of action is two-fold:
Common questions about Refresh Optive Mega-3
Carboxymethylcellulose is primarily used as a lubricant to relieve symptoms of dry eye, such as burning, irritation, and discomfort. It acts as an artificial tear by supplementing the eye's natural mucin layer and providing a protective shield over the cornea. Beyond ocular use, it is also utilized as a pharmaceutical aid (excipient) in tablets and occasionally as a bulk-forming agent for digestive health. In some specialized clinical settings, it is used as a diagnostic allergen to test for sensitivities to cellulose derivatives. Most patients use it over-the-counter to soothe eyes irritated by wind, sun, or digital screen use.
The most common side effect of Carboxymethylcellulose eye drops is temporary blurred vision immediately after application, which usually clears within a minute or two. Some users may also experience a mild, transient stinging or burning sensation upon instilling the drops, particularly if their eyes are very dry. Occasionally, a clear or white crusty residue may form on the eyelashes as the liquid dries. These effects are generally mild and do not require medical intervention. If you experience persistent eye pain, redness, or a change in vision, you should consult your healthcare provider.
Yes, there are no known direct drug interactions between alcohol and Carboxymethylcellulose. Since the medication is applied topically to the eye and is not absorbed into the bloodstream, alcohol does not interfere with its mechanism. However, it is important to note that alcohol consumption can cause systemic dehydration, which often worsens the symptoms of dry eye. While drinking alcohol is safe in relation to the drug itself, it may counteract the benefits of the treatment. Maintaining proper hydration is key to managing ocular surface disease.
Carboxymethylcellulose is generally considered safe for use during pregnancy. Because the molecule is too large to be absorbed into the systemic circulation from the eye, it does not reach the bloodstream or the developing fetus. It is often recommended for pregnant women who experience 'dry eye of pregnancy' due to hormonal changes. No studies have shown any link between CMC and birth defects or other pregnancy complications. As a standard precaution, always inform your obstetrician about any medications, including over-the-counter eye drops, that you are using during pregnancy.
Carboxymethylcellulose begins to work almost instantly upon contact with the eye surface. Most patients experience immediate relief from the 'gritty' or burning sensation associated with dry eye within seconds of application. The duration of this relief depends on the concentration of the solution; a 0.5% solution may provide comfort for 20-30 minutes, while a 1.0% 'gel drop' can last significantly longer. For chronic dry eye sufferers, the full therapeutic benefit of maintaining a healthy ocular surface may take several days of consistent, scheduled use. If symptoms do not improve within 72 hours, a doctor should be consulted.
Yes, you can stop using Carboxymethylcellulose suddenly without any risk of withdrawal or 'rebound' symptoms. Unlike some nasal sprays or redness-relief eye drops, CMC is not habit-forming and does not cause the body to stop producing its own tears. However, because CMC is treating the symptoms of dry eye rather than curing the underlying cause, your symptoms will likely return once you stop the lubrication. If you were using it post-surgery, you should follow your surgeon's specific timeline before discontinuing use to ensure proper healing. There is no need to taper the dose.
If you miss a dose of Carboxymethylcellulose, simply apply the drops as soon as you remember. Since this medication is typically used on an 'as needed' basis for symptom relief, missing a dose is not harmful and will not impact your long-term health. You do not need to apply extra drops to make up for the missed one, as the eye can only hold a very small amount of fluid at once. Simply resume your normal schedule or use the drops whenever your eyes feel dry or irritated. If your doctor has prescribed a specific schedule, try to adhere to it as closely as possible.
No, Carboxymethylcellulose does not cause weight gain. It is a non-absorbed polymer used topically in the eye or as an inert ingredient in oral medications. It has no caloric value that the body can process, and it does not affect the metabolic processes, hormones, or appetite centers that regulate body weight. Even if ingested orally as a bulk-forming agent, it passes through the digestive tract without being absorbed into the body. Any weight changes experienced while using CMC would be due to other factors or medications and should be discussed with a healthcare provider.
Carboxymethylcellulose can be used alongside most other medications, but timing is important when using other eye drops. If you are using medicated drops for glaucoma, infections, or allergies, you should apply those first, wait about 10 minutes, and then apply the Carboxymethylcellulose. This prevents the CMC from acting as a barrier that might block the absorption of the other medicine. There are no known interactions with oral medications, as CMC does not enter the bloodstream. Always provide your doctor with a full list of all medications and supplements you are currently using.
Yes, Carboxymethylcellulose sodium is widely available as a generic medication and is the active ingredient in many store-brand 'Lubricant Eye Drops.' It is also the active component in well-known brand-name products like Refresh Tears®. Generic versions are required by the FDA to have the same concentration and quality as the brand-name equivalents, making them a cost-effective alternative. When purchasing a generic, ensure that you check whether it is 'preserved' or 'preservative-free' to match your specific needs. The generic versions are available in both multi-dose bottles and single-use vials.
Other drugs with the same active ingredient (Carboxymethylcellulose)
Rarely, patients may develop a sensitivity to the components of the solution:
While Carboxymethylcellulose is not systemically toxic, serious localized reactions or contamination-related issues can occur.
> Warning: Stop taking Carboxymethylcellulose and call your doctor immediately if you experience any of these:
Carboxymethylcellulose is generally safe for long-term use. Unlike 'redness relief' drops (vasoconstrictors), CMC does not cause 'rebound redness.' However, long-term use of preserved CMC drops can lead to a condition called medicamentosa, where the preservatives (like benzalkonium chloride, though less common in modern CMC) actually damage the corneal cells. This is why long-term users are often switched to preservative-free versions. There is no evidence that long-term use of CMC affects internal eye pressure or contributes to cataract formation.
No FDA black box warnings have been issued for Carboxymethylcellulose. It is considered one of the safest pharmacological agents available for ocular health. The primary regulatory focus is on manufacturing quality and the prevention of microbial contamination.
Report any unusual symptoms to your healthcare provider.
To avoid contamination, do not touch the tip of the container to any surface, including the eye or skin. Always replace the cap after use. If the solution changes color or becomes cloudy, discard it immediately and start a new bottle.
Dry eye can sometimes be a symptom of a systemic autoimmune disease, such as Sjogren’s Syndrome, Rheumatoid Arthritis, or Lupus. If your dry eye is severe and accompanied by dry mouth, joint pain, or fatigue, Carboxymethylcellulose may only be treating the symptom and not the cause. A full medical evaluation is recommended.
There are no specific lab tests (like blood counts or liver function tests) required for patients using Carboxymethylcellulose. However, patients with chronic dry eye should have regular slit-lamp examinations by an optometrist or ophthalmologist to monitor the health of the corneal surface and ensure that the lubrication is sufficient to prevent scarring.
Carboxymethylcellulose causes temporary blurring of vision immediately after application. Do not drive, operate heavy machinery, or engage in any activity requiring clear vision until you are certain your vision has returned to its baseline. This usually takes 1 to 5 minutes, depending on the viscosity of the drop.
There are no known direct interactions between alcohol consumption and Carboxymethylcellulose. However, alcohol is a known dehydrating agent and can exacerbate the symptoms of dry eye. Reducing alcohol intake may improve the efficacy of the treatment.
There are no tapering requirements for Carboxymethylcellulose. You can stop using it at any time without risk of withdrawal or physical rebound. However, if the underlying cause of your dry eye has not been resolved, your symptoms (burning, redness, irritation) will likely return shortly after you stop using the drops.
> Important: Discuss all your medical conditions with your healthcare provider before starting Carboxymethylcellulose.
Many Carboxymethylcellulose formulations (especially multi-dose bottles) contain preservatives that can be absorbed by soft contact lenses. This can lead to lens discoloration and localized irritation.
There are no known food interactions with Carboxymethylcellulose. It does not interact with grapefruit juice, dairy, or high-fat meals. However, a diet rich in Omega-3 fatty acids (found in fish oil and flaxseed) has been shown in clinical studies to work synergistically with CMC to improve the quality of the natural tear film.
There are no documented interactions between Carboxymethylcellulose and common herbal supplements like St. John’s Wort or Ginkgo Biloba. Patients using herbal supplements for eye health (such as Lutein or Bilberry) can continue to use CMC safely.
Carboxymethylcellulose does not interfere with standard blood or urine lab tests. In the context of its use as a Non-Standardized Chemical Allergen, it may be used during a lab-controlled patch test, where its presence is the variable being measured. It does not cause false positives or negatives on unrelated diagnostic tests.
| Interaction Type | Mechanism | Clinical Consequence | Management |
|---|---|---|---|
| Topical Ophthalmic Meds | Physical Barrier Formation | Reduced efficacy of the second drug | Wait 10 minutes between drops |
| Soft Contact Lenses | Preservative Absorption | Lens damage and eye irritation | Remove lenses for 15 mins |
| Oral Medications | Binding (if CMC is ingested) | Delayed absorption of oral drugs | Take oral meds 2 hours apart from CMC |
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
These conditions require a careful risk-benefit analysis by a healthcare professional:
Patients who are allergic to other cellulose-based products may show cross-sensitivity to Carboxymethylcellulose. These include:
If you have had an adverse reaction to any 'artificial tear' product in the past, review the active and inactive ingredients with your pharmacist to identify if a cellulose derivative was the cause.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Carboxymethylcellulose.
Dry eye syndrome is significantly more prevalent in patients over the age of 65 due to the natural atrophy of the lacrimal glands. Geriatric patients may have difficulty with the manual dexterity required to squeeze small eye drop bottles.
Carboxymethylcellulose does not enter the systemic circulation and is not cleared by the kidneys. Therefore, no dosage adjustments are necessary for patients with any stage of chronic kidney disease (CKD) or those on dialysis.
Since CMC is not metabolized by the liver, it is safe for use in patients with hepatic cirrhosis or liver failure without any modification to the standard dosing regimen.
> Important: Special populations require individualized medical assessment.
| Parameter | Value |
|---|---||
| Bioavailability | 0% (Topical/Oral) |
| Protein Binding | N/A (Not systemically present) |
| Half-life | 15–45 minutes (Ocular surface residence) |
| Tmax | Immediate (Local effect) |
| Metabolism | None (Biologically inert) |
| Excretion | Nasolacrimal drainage / Fecal |
Carboxymethylcellulose is classified as an Ophthalmic Lubricant and a Cellulose Derivative. Within the FDA's Established Pharmacologic Class (EPC) system, it is also categorized as a Non-Standardized Chemical Allergen, reflecting its use in diagnostic immunological testing.